About
Envista's site notes Mark Nance joined in 2019 ahead of the IPO and serves as SVP, General Counsel, with nearly 20 years of experience as a general counsel. He was previously Chief Legal Officer of INSYS Therapeutics, General Counsel of Mylan N.V., and led the legal teams at GE Healthcare Medical Diagnostics and Life Sciences; his public service includes the U.S. Federal Trade Commission, the U.S. Marine Corps, and the National Science Advisory Board for Biosecurity. He holds a BA from the University of Missouri and a JD from Cornell Law School.
Roles
Envista Holdings Corp.
Senior Vice President, General Counsel and Secretary · Current role
2019–present
INSYS Therapeutics, Inc.
Chief Legal Officer
—
Mylan N.V.
Senior Vice President and Global General Counsel
—
GE Healthcare
General Counsel, Medical Diagnostics and Life Sciences
—
Mylan N.V.
General Counsel
—
GE Healthcare
Legal leadership, Medical Diagnostics and Life Sciences
—
Fixed Compensation
FY 2025
All other compensation
$33,986
Total compensation
$2,645,186
Performance Compensation
Data from FY 2025
Cash incentive
Non-equity incentive plan compensation
$551,425
Stock awards
Also at Envista Holdings Corp.